Abstract
Nanoparticles are promising materials in research and industrial fields because of their unique characteristics, their safety and toxicity are still being investigated. Although the safety and toxicity of nanomaterials are predicted by animal experiments, obtained results may be inconsistent with human outcomes due to the species difference. Recently, there has been an increasing interest in in vitro lung models, which allow control of experimental parameters and quantitative analyses, for the prediction of lung injuries and translocation into secondary organs of nanoparticles. In this section, we focus on developing in vitro alveolar models consisting of not only human-derived cell lines but also primary rat cells as complementary methods for intratracheal instillation in rats. We also coculture with macrophages to approach physiologically relevant alveolar environment. In addition, cytotoxicity and permeability tests of nanoparticles are presented to evaluate the in vitro alveolar coculture modles developed here. To further improve the physiological relevance of in vitro alveolar models, we discuss future issues.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nano level. Science. 2006;311:622–7.
De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int J Med. 2008;3:133–49.
Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol. 2007;25:563–70.
Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol. 2012;86:1137–51.
Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007;97:163–80.
Yacobi NR, Phuleria HC, Demaio L, Liang CH, Peng CA, Sioutas C, Borok Z, Kim KJ, Crandall ED. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicol In Vitro. 2007;21:1373–81.
Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009;69:8784–9.
Gurr JR, Wang ASS, Chen CH, Jan KY. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology. 2005;213:66–73.
Kim IS, Baek M, Choi SJ. Comparative cytotoxicity of Al2O3, CeO2, TiO2 and ZnO nanoparticles to human lung cells. J Nanosci Nanotechnol. 2010;10:3453–8.
Lai JCK, Lai MB, Jandhyam S, Dukhande VV, Bhushan A, Daniels CK, Leung SW. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Int J Nanomedicine. 2008;3:533–45.
Lin W, Huang YW, Zhou XD, Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006;217:252–9.
Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev. 2011;111:5610–37.
Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17:62–70.
Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243:359–66.
Daigneault M, Preston JA, Marriott HM, Whyte KB, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010;5:e8668.
Fleit HB, Kobasiuk CD. The human monocyte-like cell line THP-1 expresses FcγRI and FcγRII. J Leukoc Biol. 1991;49:556–65.
Braakhuis HM, Kloet SK, Kezic S, Kuper F, Park MVDZ, Bellmann S, van der Zande M, Gac SL, Krystek P, Peters RB, Rietjents IMCM, Bouwmeester H. Progress and future of in vitro models to study translocation of nanoparticles. Arch Toxicol. 2015;89:1469–95.
Dobbs LG, Mason RJ. Pulmonary alveolar type II cells isolated from rats. J Clin Invest. 1979;63:378–87.
Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev. 2006;58:1030–60.
Wallace WAH, Gillooly M, Lamb D. Intra-alveolar macrophage numbers in current smokers and non-smokers: a morphometric study of tissue sections. Thorax. 1992;47:437–40.
Iwasawa K, Tanaka G, Aoyama T, Chowdhury MM, Komori K, Tanaka-Kagawa T, Jinno H, Sakai Y. Prediction of phthalate permeation through pulmonary alveoli using a cultured A549 cell-based in vitro alveolus model and a numerical simulation. AATEX. 2013;18:19–31.
Komori K, Murai K, Miyajima S, Fujii T, Mohri S, Ono Y, Sakai Y. Deveopment of an in vitro batch-type closed gas exposure device with an alveolar epithelial cell line, A549, for toxicity evaluations of gaseous compounds. Anal Sci. 2008;24:957–62.
Whitcutt MJ, Adler KB, Wu R. A biphasic chamber system for maintaining polarity of differentiation of cultured respiratory tract epithelial cells. In Vitro Cell Dev Biol. 1988;24:420–8.
Sakai Y, Tomita K, Suzuki M, Ono Y, Sakoda A. Development of a toxicity evaluation system for gaseous compounds using air-liquid interface culture of a human bronchial epithelial cell line. Calu-3 AATEX. 2005;11:59–67.
Weibel ER. Morphometry of the human lung: the state of the art after two decades. Bull Eur Physiopathol Respir. 1979;15:999–1013.
Dobbs LG, Pian MS, Magrio M, Dumars S, Allen L. Maintenance of the differentiated type II cell phenotype by culture with an apical air surface. Am J Physiol. 1997;273:L347–54.
Huh D, Matthews BD, Mammoto A, Montoya-Zavala H, Hsin Y, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–8.
Acknowledgements
The works shown here are collaborative work with Mr. Takuya Aoyama, Mr. Kodai Harano, Ms. Xinying Xu, and Ms. Ayaka Uemura. This work is part of the research program “Development of innovative methodology for safety assessment of industrial nanomaterials” supported by the Ministry of Economy, Trade and Industry (METI) of Japan.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Komori, K., Iwasawa, K., Ogasawara, R., Suwabe, A., Sakai, Y. (2019). In Vitro Alveolar Epithelial Models Toward the Prediction of Toxicity and Translocation of Nanoparticles: A Complementary Method for Mechanism Analyses in Humans. In: Takebayashi, T., Landsiedel, R., Gamo, M. (eds) In Vivo Inhalation Toxicity Screening Methods for Manufactured Nanomaterials. Current Topics in Environmental Health and Preventive Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-13-8433-2_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-8433-2_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8432-5
Online ISBN: 978-981-13-8433-2
eBook Packages: MedicineMedicine (R0)